Matthew B Palmer Selected Research

Melanoma (Melanoma, Malignant)

7/2007

A 3' enhancer controls snail expression in melanoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew B Palmer Research Topics

Disease

9	Neoplasms (Cancer) 07/2021 - 12/2011
4	Proteinuria 07/2021 - 01/2016
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 07/2014
3	Chronic Kidney Failure (Chronic Renal Failure) 11/2020 - 04/2015
3	Prostatic Neoplasms (Prostate Cancer) 04/2013 - 10/2003
2	Hypertension (High Blood Pressure) 11/2021 - 07/2021
2	Thrombotic Microangiopathies 07/2021 - 01/2016
2	Amyloidosis 01/2019 - 04/2015
2	Glomerulonephritis 01/2018 - 05/2017
2	Neoplasm Metastasis (Metastasis) 11/2014 - 11/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2014 - 10/2013
2	Esophageal Neoplasms (Esophageal Cancer) 01/2012 - 12/2011
1	Ischemia 11/2022
1	renal Oncocytoma 05/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2022
1	Diabetes Mellitus 11/2021
1	Albuminuria 10/2021
1	Bites and Stings (Sting) 10/2021
1	Kidney Diseases (Kidney Disease) 10/2021
1	Atypical Hemolytic Uremic Syndrome 07/2021
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 12/2019
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 12/2019
1	Primary Myelofibrosis (Myelosclerosis) 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Vasculitis (Vasculitides) 05/2017
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2017
1	Nephritis 01/2017
1	Infections 01/2017
1	Multiple Myeloma 01/2016
1	Radiation-Induced Neoplasms (Neoplasms, Radiation Induced) 08/2014
1	Medulloblastoma 08/2014
1	Rectal Neoplasms (Rectal Cancer) 06/2011
1	Carcinoma (Carcinomatosis) 06/2011
1	Melanoma (Melanoma, Malignant) 07/2007

Drug/Important Bio-Agent (IBA)

2	InterferonsIBA 10/2021 - 05/2017
2	LigandsIBA 07/2021 - 01/2017
2	Antiviral Agents (Antivirals)IBA 05/2017 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2015
2	CreatinineIBA 01/2016 - 04/2015
2	Protons (Proton)IBA 08/2014 - 04/2013
1	CytokinesIBA 11/2022
1	Chemotactic FactorsIBA 11/2022
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 05/2022
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 10/2021
1	Apolipoprotein L1IBA 10/2021
1	Disulfiram (Antabuse)FDA Link 10/2021
1	NucleotidesIBA 10/2021
1	InflammasomesIBA 10/2021
1	Angiogenesis InhibitorsIBA 07/2021
1	Monoclonal AntibodiesIBA 07/2021
1	eculizumab FDA Link 07/2021
1	Bevacizumab (Avastin)FDA Link 07/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2021
1	SilverIBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Periodic AcidIBA 01/2021
1	Lenalidomide (CC 5013)FDA Link 12/2019
1	A-factor (Streptomyces)IBA 01/2019
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2019
1	ruxolitinibIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Complement Factor H (Factor H)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2017
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2016
1	carfilzomibIBA 01/2016
1	Proteasome InhibitorsIBA 01/2016
1	Bortezomib (Velcade)FDA Link 01/2016
1	Amyloidogenic ProteinsIBA 04/2015
1	Amyloid (Amyloid Fibrils)IBA 04/2015
1	ChromatinIBA 07/2007
1	DNA Transposable Elements (Element, IS)IBA 07/2007

Therapy/Procedure

9	Proton Therapy 01/2021 - 12/2011
7	Radiotherapy 01/2021 - 06/2011
4	Therapeutics 05/2017 - 12/2011
2	Nephrectomy 11/2021 - 11/2020
2	Re-Irradiation 11/2014 - 10/2013
1	Conformal Radiotherapy 01/2012
1	Chemoradiotherapy 12/2011
1	Brachytherapy 10/2003